companydata.dkBactiQuant A/S
CVR: 24231712
Secondary names: MYCOTEC A/S, Bactimatic A/S
Previous names: MYCOTEC ApS, MYCOMETER ApS, MYCOMETER A/S
BactiQuant A/S is currently experiencing significant financial challenges, characterized by consistent losses over the past four years. Revenue peaked at 12.3 million DKK in 2023 but has declined to 7.2 million DKK in 2024, indicating a troubling downward trend. The company's equity has also decreased sharply from 21 million DKK in 2021 to just 689,233 DKK in 2024, raising concerns about its financial stability and ability to sustain operations. With negative profit margins and a lack of profitability, BactiQuant's position within the research and experimental development sector appears precarious, necessitating strategic adjustments to improve its financial health.
AI-generated summary
Overview
- Company type
- A/S
- Aktieselskab
- Founded
- 1.7.1999
Details
- Employees
- 17 employees
- 8 FTE
- (2018)
- Capital
- 1.876.092,8 kr.
Contact
Advertising protected- Phone
- Log in to see
- Log in to see
- Website
- www.bactiquant.com
Purpose
Selskabets formål er at drive virksomhed med fremstilling og salg af mikrobiologiske metoder til måling af mikrobiel kontaminering, og dermed beslægtet virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 7.2 mio. | -13.7 mio. | 14.7 mio. | 689 t. | 11 | |
History
Ownership
Management
Directors
Board
Production units (1)
Similar companies
Companies in the same industry and area